IDE IDE
Company Profile ↓Company Overview
IDE (IDE) is a publicly traded company listed on with a market capitalization of $197.64M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +16.20% |
| 6 Months: | +2.71% |
| 3 Months: | -3.70% |
| 1 Month: | +0.92% |
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)45.88 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Balance Sheet (Annual)
Figures in USD.
| Metric | Feb 2022 | Feb 2023 | Feb 2024 | Feb 2025 | Feb 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 177.40M | 180.47M | 174.74M | 221.82M |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 64.85K | 27.76K | 26.72K | 75.01K |
| Inventory | - | - | - | - | - |
| Receivables | - | 316.80K | 760.86K | 1.70M | 1.63M |
| Total Liabilities | - | 603.85K | 2.86M | 729.23K | 3.31M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
| Total Equity | - | 176.80M | 177.62M | 174.02M | 218.51M |
| Shares Outstanding | - | 15.71M | 15.16M | 15.16M | 15.16M |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for IDE
Voya Infrastructure, Industrials And Materials Fund Q2 2026 Commentary - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQVXhZaHYza04xUlZPa1JQMllWYTY0bklrd3VnOHlQb3ZRaXpPMUtRaGE2aHAtR0VBTXhkZkFhYjFYbVV5TDlnX3Eyb3FXZ3RJb1oyQi0wQXQxZ2RKdnBMWi1EV1FTOVlqcjFCQXRJUl9KN3p1ZzJTZlh2b3NYVjRYY2x5R0dtSUo5Nmwwbm…
(IDE) Volatility Zones as Tactical Triggers - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxOZGszOWdkUDd6NEY1bmJENG1OVE4yQUwzd1ZyRjlMMFc2TllpSmRiSUFCeE5qN0MzNVRETFNEUks2LVFDZmxhekx1Y1kyLVJ1TzlDa1NMNDRCMlZhQTBXWndIWVNJZXp4bVU1c2JsMnd3SjJsUzJEbXdWZlV2cHNfM1VETnRiaG5KcndVVn…
Reasons to Retain TransMedics Stock in Your Portfolio for Now - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQYVlVOUVWODhuOGE5emt4RzVhSlNzaS1RdFZ0X0xnRU00WVZpdTRGcl84QjNIclVoZmhSaDVoQTZBZXM4RVNFcGNhM0dUeFJRaDF1TlU4V19HTmk2NWREZkRGXzNqMkpENXNJejRwUm5zOWxrT2dHR19Dczd0YmNkUEluM1A0NExfRkF1Zm…
VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND (IDE) - Live Price & How to Invest from India - INDmoney
<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE93Wk1SVEFhLVk5ZHBXMWpHYmstSDVhTGtUUHVsc29HNmdKMDA0YktWV09xNGhOUWNDOFdUQ3pYR3RDSE5rdGRJcEpta1QtYWdUWWEzUzd3?oc=5" target="_blank">VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND…
Japan stocks soar, super-long bonds steady in nod to Takaichi's 'responsible' stimulus - Reuters
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxOWTlQTHZzemk5V1EyNXFIZTNvZVNxS1ZHZFZrR1l5ZmpCLTlnMmFGNGdmS0RrRG5HaHZ4Z1JWR0ZKZ1hQU3lUZjFZRmhJdGphalR6QmtoLTlRdWNPNzdVTDNkT1U0NVpwT0hWWXZJdk11QjNkSUIwUVotNzRkWjI5bTBqZWdBWjM1cUFuVH…
Vivos’ IsoPet Has Treated 200+ Animals at 17 U.S. Clinics - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOMjZXelAzTjdIOVVoaDNRcjI3SVQzdTVnZEZzTTNrTW5pcEd6QktZTl9FVk9vb0d2WHE4WXhQRVdIQzk3S2JFYkdvejZSWGR1Y0EySmx4RVBNX3cyWk9PZFBVVGdCTWpPX0hCVE1RZkVtM2dvdkdaYTItXzVqNGhEWEZRYkZuYzVKVzdJTm…
IDE — Frequently Asked Questions
What is the current share price of IDE?
As of 2026-09-07 16:24 PDT, IDE trades at $13.04 on NASDAQ/NYSE. Its 52-week range is $10.53 to $13.69.
What is the market capitalisation of IDE?
IDE has a market capitalisation of $197.64M on NASDAQ/NYSE.
Is IDE a good stock to buy?
This page provides a data-driven analysis of IDE, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.